The safety of steroid withdrawal in orthotopic liver transplant (OLT) recipients has been
studied in a prospective trial with a comparison control group. Sixty-four recipients of ABO …

Background: Graft rejection and infection remain major problems following liver
transplantation; both are heavily influenced by the immunosuppressive regimen. Despite the …

In a total of 1004 patients in 11 controlled trials, treatment with ursodeoxycholic acid (UDCA)
8-15 mg/kg bodyweight per day led to a decrease of pruritus in 30–60% of cases, a …

Irreversible ductopenic rejection (DR) after orthotopic liver transplantation (OLT) is a major
cause of late hepatic allograft failure. A variety of risk factors for DR have been postulated …

The appropriate time point for starting immunosuppressive treatment with calcineurin
inhibitors after orthotopic liver transplantation (OLT) has been a subject of debate. The aim …

Background: In the immunosuppression of orthotopic liver transplant recipients, steroids are
used despite their unspecific action and long-term side effects. Few studies have been …

Introduction Acute cellular rejection (ACR) post-liver transplantation (LT) can usually be
reversed with pulse dose steroids. Anti-thymocyte globulin (ATG) is used to treat steroid …

As improvements in surgical technique, organ preservation, immunosuppression, intensive
medical care, and diagnosis and treatment of infectious disease have increased survival …

Corticosteroid withdrawal after orthotopic liver transplantation (OLT) represents an attractive
therapeutic option for ameliorating post-OLT metabolic complications, although several …

To assess the efficacy of ursodeoxycholic acid (UDCA) in autoimmune hepatitis we
administered UDCA (600 mg/day, orally) to four patients who had autoimmune hepatitis …